Despite advances in PCI and lipid-lowering therapy, substantial residual cardiovascular risk persists in coronary artery disease (CAD) patients even after achieving LDL-C targets. Remnant cholesterol (RC) from triglyceride-rich lipoproteins is an independent causal driver of this risk. ANGPTL3 and ANGPTL4 regulat...
Y. Cao, Q. Sun, J. Zhang et al.· European Heart Journal· 0 citations
This meta-analysis suggests that high Lp(a) levels are associated with several imaging-defined high-risk coronary plaque features, with the most robust evidence observed for OCT-derived TCFA and plaque rupture.
J. Zhang, Yang Tang, Y. Cao et al.· International Journal of Car...· 0 citations
Integrating systemic inflammation, particularly SIRI, with the TyG index significantly enhances long-term cardiovascular risk reclassification in CAD patients, and this simple and cost-effective approach based on routine laboratory parameters may improve risk stratification and support more targeted secondary preventio...
Z. Ma, P. Zhu, Jing-Jing Xu et al.· Coronary Artery Disease· 0 citations
Chronic inflammation and insulin resistance (IR) are key drivers of cardiovascular disease (CVD); however, their joint impact on cardiovascular risk remains poorly understood.
Meng-Lu Liu, N. Xu, Geng-Yu Sha et al.· Diabetes, obesity and metabo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.